Investigations into the role of anti-HLA class II antibodies in TRALI.
about
Transfusion-related acute lung injury (TRALI): a serious adverse event of blood transfusionGeneration of inflammatory cytokines and chemokines from peripheral blood mononuclear cells by HLA Class II antibody-containing plasma unit that was associated with severe nonhemolytic transfusion reactions.The role of neutrophils in the pathogenesis of transfusion-related acute lung injury.Transfusion-related acute lung injury (TRALI): current concepts and misconceptions.Transfusion-related acute lung injury: a literature review.The pathogenesis of transfusion-related acute lung injury (TRALI).Transfusion-related acute lung injury surveillance (2003-2005) and the potential impact of the selective use of plasma from male donors in the American Red Cross.Antibody-mediated transfusion-related acute lung injury; from discovery to prevention.Impact of a transfusion-related acute lung injury reduction strategy on apheresis platelet collections.Antibodies to major histocompatibility complex class II antigens directly prime neutrophils and cause acute lung injury in a two-event in vivo rat model.Enhancement of endothelial permeability by coculture with peripheral blood mononuclear cells in the presence of HLA Class II antibody that was associated with transfusion-related acute lung injury.Transfusion-related acute lung injury and leucocyte-reacting antibodies.Massive blood transfusion and outcome in 1062 polytrauma patients: a prospective study based on the Trauma Registry of the German Trauma Society.Flow-cytometric approach to the prompt laboratory diagnosis of TRALI: a case report.Antibodies to the HLA-A2 antigen prime neutrophils and serve as the second event in an in vitro model of transfusion-related acute lung injury.
P2860
Q28254823-C6ADD1AF-52B6-40CB-8FEE-7DA8126F3C06Q33373786-568C8153-F57E-4D0E-B6CE-9522F12EA602Q34118409-7BD5C547-A7DC-4B1D-B5B8-3FB03D23496DQ35100910-11FFB049-C0B2-4E71-98C4-13C383DCF564Q36546623-173E5AA0-2587-4768-B4E1-D5351E8919DBQ36753034-A601E0C5-3425-4875-95CC-12F68D2F798BQ36768372-F1B9035B-67CE-4F3E-A37A-43946BE94FEDQ38447155-26E6EDAA-6D8A-4AD2-B920-35D5DA827C6DQ47850031-E0A38EEC-50A2-4FA9-B115-489702D27626Q49408761-B0F2053A-E2B5-48B3-A006-094155723FF8Q50556977-A4785C3C-9E30-4B8F-BE02-8FE7BD992D40Q50692594-96EDA47A-FBBC-42A8-BC90-F8686F767647Q50710896-D35363D9-F960-4082-8B5C-B862C41749AAQ51990513-BC1605A2-9293-4C62-B0CE-EC7DE3A64720Q54392752-8BD1D676-6CF8-41D0-A69B-15E6F7367ADB
P2860
Investigations into the role of anti-HLA class II antibodies in TRALI.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Investigations into the role of anti-HLA class II antibodies in TRALI.
@en
Investigations into the role of anti-HLA class II antibodies in TRALI.
@nl
type
label
Investigations into the role of anti-HLA class II antibodies in TRALI.
@en
Investigations into the role of anti-HLA class II antibodies in TRALI.
@nl
prefLabel
Investigations into the role of anti-HLA class II antibodies in TRALI.
@en
Investigations into the role of anti-HLA class II antibodies in TRALI.
@nl
P2093
P2860
P1433
P1476
Investigations into the role of anti-HLA class II antibodies in TRALI.
@en
P2093
David M Dorfman
Edgar L Milford
Grace S Kao
Isabelle G Wood
Richard J Benjamin
P2860
P304
P356
10.1046/J.1537-2995.2003.00285.X
P577
2003-02-01T00:00:00Z